New Delhi, India – The unprecedented outbreak of monkeypox disease in several countries has kept India on its toes, with the Centre saying it is closely monitoring the infection’s progress. With many countries reporting cases of monkeypox, the Union Health Ministry advised all states to direct hospitals to keep an eye out for symptomatic patients who have recently travelled to the affected countries and isolate them at designated healthcare facilities.
The ministry recently directed airport and port health officials to increase surveillance, isolate symptomatic travellers from monkeypox-affected countries, and send their samples to the NIV for investigation. Meanwhile, several states have announced plans to prepare for a situation in which monkeypox cases are reported.
Should we be concerned by the health ministry’s detection of monkeypox symptoms?
According to a health ministry official, the government’s primary goal at the moment is to identify persons who are showing signs of monkeypox sickness. “The incubation period is normally 7-14 days, although it can range from 5-21 days, and there are usually no symptoms during that time.” “The goal is to find those individuals who were overlooked during airport screening due to a lack of symptoms at health institutions once they develop the symptoms,” an official added.
The Health Ministry is developing comprehensive recommendations for the treatment and prevention of monkeypox in partnership with the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC).
According to the Indian Council of Medical Research (ICMR), no monkeypox cases have been documented in the country. The administration, on the other hand, is keeping a tight eye on the situation. According to the ICMR, youngsters are more likely to become infected with the monkeypox virus.
“Children are more vulnerable to monkeypox infection.” The elderly would be immunised with the smallpox vaccine. “After the 1980s, people who did not receive the smallpox vaccine that provides cross-immunity to combat the virus, thus the younger people will be more susceptible,” ICMR scientist Dr Aparna Mukherjee said.